Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

First interim dividend

17 Jan 2025 17:14

RNS Number : 8458T
Experian plc
17 January 2025
Β 

Experian plc

Β 

Β 

First interim dividend - exchange rate and Irish dividend withholding tax

Β 

Β 

17 January 2025 - Experian plc, the global information services company, hereby notifies the market that, further to the announcement on 13 November 2024 of a first interim dividend of 19.25 US cents per ordinary share payable on 7 February 2025 to shareholders on the register of members at the close of business on 10 January 2025, the exchange rate to be used to convert the dividend payment from US dollars to sterling pounds, for those shareholders who did not elect by 10 January 2025 to receive payment in US dollars, will be Β£1 = $1.21984 Accordingly, the sterling amount of dividend payable on 7 February 2025 to such shareholders will be approximately 15.7807 pence per share.

Β 

Shareholders who did not elect to receive UK sourced dividends through the income access share arrangements are reminded that, as previously advised, their dividends will be subject to Irish dividend withholding tax unless the Company's Registrars are in possession of a valid exemption form. As previously advised, the final date for submission of elections to receive UK sourced dividends via the income access share arrangements was 10 January 2025. In the absence of any such elections, previous elections or deemed elections will remain in force.

Β 

Contact:

Β 

Experian

Charles Brown

Company Secretary

+353 (0) 86 819 4473

Β 

Β 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

Β 

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

Β 

We invest in talented people and new advanced technologies to unlock the power of data and innovate. As a FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 22,500 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DIVFLFLDLFIDLIE
Date   Source Headline
10th Feb 20267:00 amRNSTransaction in Own Shares
9th Feb 20265:05 pmRNSDirector/PDMR Shareholding
9th Feb 20267:00 amRNSTransaction in Own Shares
6th Feb 20267:00 amRNSTransaction in Own Shares
5th Feb 20261:00 pmRNSDirector/PDMR Shareholding
5th Feb 20267:00 amRNSTransaction in Own Shares
4th Feb 20267:00 amRNSTransaction in Own Shares
3rd Feb 20267:00 amRNSTransaction in Own Shares
2nd Feb 20267:00 amRNSTransaction in Own Shares
30th Jan 20262:49 pmRNSTotal Voting Rights
30th Jan 20267:00 amRNSCapital allocation update
27th Jan 20261:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading update, third quarter
16th Jan 20265:39 pmRNSFirst interim dividend
16th Jan 202611:41 amRNSBlock listing Return
8th Jan 20267:00 amRNSExperian plc Chair Announcement
31st Dec 202511:23 amRNSTotal Voting Rights
31st Dec 202511:23 amRNSTotal Voting Rights
19th Dec 202510:08 amRNSElections for first interim dividend
19th Dec 202510:08 amRNSElections for first interim dividend
1st Dec 20257:00 amRNSTransaction in Own Shares
28th Nov 202512:35 pmRNSTotal Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20255:15 pmRNSHolding(s) in Company
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20259:30 amRNSDirector/PDMR Shareholding
13th Nov 20259:30 amRNSDirector/PDMR Shareholding
12th Nov 20257:00 amRNSHalf-year Financial Report
31st Oct 202511:18 amRNSTotal Voting Rights
14th Oct 20251:00 pmRNSExperian – US mortgage market update
1st Oct 202510:24 amRNSAdditional Listing
30th Sep 202511:41 amRNSTotal Voting Rights
29th Sep 20257:00 amRNSTransaction in Own Shares
26th Sep 20257:00 amRNSTransaction in Own Shares
25th Sep 20257:00 amRNSTransaction in Own Shares
24th Sep 20259:23 amRNSAdditional Listing
24th Sep 20257:00 amRNSTransaction in Own Shares
23rd Sep 20257:00 amRNSTransaction in Own Shares
18th Sep 202510:07 amRNSBlock listing Interim Review
16th Sep 20257:00 amRNSTransaction in Own Shares
15th Sep 202510:00 amRNSDirector Declaration
15th Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSTransaction in Own Shares
11th Sep 20257:00 amRNSTransaction in Own Shares
8th Sep 20257:00 amRNSTransaction in Own Shares
5th Sep 20257:00 amRNSTransaction in Own Shares
4th Sep 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.